The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) reports 2020 data and some 2021 features of the Alabama PDMP.
Alabama’s PDMP name is Prescription Drug Monitoring Program, which is managed by the Alabama Department of Public Health. The PDMP email address is provided, along with the PDMP website URL and separate URLs of websites for enrollment, query, and data upload. Contact information is provided for the State Pharmacy Director and the PDMP Administrator. Statistics for the year 2020 are reported to be 5,030,053 for the state population; 18,419 DEA-registered prescribers; and 1,336 DEA-registered dispensers. Three types of PDMP reports are available to prescribers, two for dispensers, four for the Licensing Board, and three for law enforcement. Nine other types of reports are checked. PDMP budget and staffing for 2021 indicates funding sources from the state general fund, controlled substance registration fee, and CDC grant. There is one operational employee for 2021. PDMP policies and procedures cover key PDMP dates, access information for relevant statutes and rules, miscellaneous capabilities and policies, data retention, PDMP user training, PDMP accounts, law enforcement requirements (active investigation and probable cause), along with access methods (online/web portal). There is required PDMP enrollment and use for only prescribers. A veterinary icon is required on PDMP reports; they cannot access PDMP data but can voluntarily report to the PDMP; they are not permitted by statute/rule/policy to query. Data monitored or accessible covers schedules II, III, IV, and V.
Similar Publications
- Revisiting Neighborhood Context and Racial Disparities in Drug Arrests Under the Opioid Epidemic
- Impact of Methamphetamine Enforcement on the Criminal Justice System of Southwestern Indiana (From Policing in Central and Eastern Europe: Dilemmas of Contemporary Criminal Justice, P 208-219, 2004, Gorazd Mesko, et al., eds. -- See NCJ-207973)
- Modern Policing and the Control of Illegal Drugs: Testing New Strategies in Two American Cities